Approval · Notice of Compliance 4344 · 1996
MIGRANAL: Notice of Compliance 4344
Issued October 4, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4344
- Date
- October 4, 1996
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Migraine therapy
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIGRANAL | 02228947 | Marketed |
Medicinal ingredients
- DIHYDROERGOTAMINE MESYLATE 4 MG per ML